# Phase 2 Completion Report: Explainable Healthcare Release Rollback Adviser

**Project Name:** Explainable Healthcare Release Rollback Adviser  
**Phase:** Phase 2 Complete (Engineering Prototype & Reproducibility)  
**Date:** September 2026  
**Environment:** TypeScript / Node.js 22 / React 19 / Express / Vite / Python 3.10  

---

## 1. Project Objective

The objective of the Explainable Healthcare Release Rollback Adviser is to transform manual, intuition-driven software release rollback decisions across multi-hospital deployments into an **explainable, data-driven, and audited operational workflow**. By fusing technical microservice telemetry (latency degradation, error rate spikes, transaction drops, service availability) with business and customer impact indicators (clinical workflows affected, customer impact severity), the system delivers transparent risk scores, triggered rule evidence, and actionable recommendations (`ROLLBACK RECOMMENDED`, `HUMAN REVIEW`, `CONTINUE`) while enforcing strict human confirmation safeguards.

---

## 2. Phase 1 Baseline & Identified Improvements

The Phase 1 prototype established:
- Functional full-stack prototype with React frontend and backend evaluation engine.
- Configurable deterministic risk rules R1–R6.
- 512 synthetic hospital release records across 5 hospital tenants.
- Advisory-only workflow with human confirmation modal and override justification.
- Two distinct organizational roles (`SOC / Operations Analyst` and `Release Manager`).
- 3 benchmark failure scenarios and 3 edge cases.
- Initial decision-time reduction metrics and preliminary stakeholder validation.

The Phase 1 evaluation specifically identified **8 required improvements**:
1. Add an explicit usability walkthrough.
2. Add a dedicated ethics/safety note.
3. Add a deployment checklist.
4. Replace generic/default README content with project-specific documentation.
5. Convert benchmark and edge-case scenarios into executable regression/failure tests.
6. Make the experiment and metrics reproducible from scripts instead of static results.
7. Explain and reconcile the baseline discrepancy between ~48.5 minutes and 38.2 minutes.
8. Continue developing the project beyond a concept or isolated prototype.

---

## 3. Phase 2 Enhancements & Deliverables

Every single improvement identified in Phase 1 has been directly designed, implemented, and verified in Phase 2:

### 3.1 Interactive Usability Walkthrough
- Added a dedicated **Usability Walkthrough** page in the application (`src/pages/WalkthroughPage.tsx`).
- Created an interactive 13-step guided operator journey:
  - Step 1: Login
  - Step 2: Select hospital
  - Step 3: Select release
  - Step 4: Review release metadata
  - Step 5: Review technical signals
  - Step 6: Review business/customer-impact signals
  - Step 7: Review calculated risk score
  - Step 8: Inspect triggered rules and evidence
  - Step 9: Review recommendation
  - Step 10: Confirm rollback / continue / human review
  - Step 11: If overriding recommendation, enter mandatory reason
  - Step 12: Review audit entry
  - Step 13: Measure decision time
- Each step explicitly articulates: **What the user sees**, **What the user should do**, and **Why the step matters**, with interactive controls and deep links to live release screens.

### 3.2 Dedicated Ethics and Safety Governance
- Authored `docs/ethics_and_safety.md` and created the UI page **Ethics & Safety** (`src/pages/EthicsSafetyPage.tsx`).
- Fully articulates the 13 safety mandates:
  1. Advisory system only.
  2. No automatic production rollback execution.
  3. Mandatory human confirmation for high-impact actions.
  4. Synthetic data clearly marked.
  5. Zero real patient health information (PHI).
  6. Explicit exclusion from Clinical Decision Support Systems (CDSS).
  7. Risk recommendations can be wrong (false positive/negative awareness).
  8. Missing or degraded telemetry flagged as "Insufficient evidence".
  9. Human operators remain legally and operationally responsible.
  10. Mandatory override justification logged for accountability.
  11. Role-based rule authorization.
  12. Immutable rule-change audit logging.
  13. Production deployment prerequisites.
- Prominent safety banner: `"ADVISORY SYSTEM — NO AUTOMATIC PRODUCTION ROLLBACK"`.

### 3.3 Deployment Readiness Checklist
- Created `docs/deployment_checklist.md` and the UI page **Deployment Readiness** (`src/pages/DeploymentChecklistPage.tsx`).
- Categorized checklist across Environment, Database, Monitoring, Security, Operation, and Validation.
- Explicitly documents prototype achievements vs. production requirements.

### 3.4 Project-Specific Documentation & README
- Replaced generic AI Studio README with a 100% project-specific, comprehensive `README.md` covering all 17 specified sections.

### 3.5 Executable Regression Test Suite
- Converted all benchmark scenarios and edge cases into an automated, executable regression test suite (`tests/` directory):
  - `TEST 1`: High latency + normal errors + stable transactions (`tests/test_risk_engine.py`)
  - `TEST 2`: High error rate + low customer impact (`tests/test_risk_engine.py`)
  - `TEST 3`: Low technical risk + CRITICAL customer impact (`tests/test_risk_engine.py`)
  - `TEST 4`: Missing latency telemetry handling (`tests/test_failure_cases.py`)
  - `TEST 5`: Zero transactions / traffic drop (`tests/test_failure_cases.py`)
  - `TEST 6`: Conflicting technical signals (`tests/test_failure_cases.py`)
  - `TEST 7`: High-impact recommendation requires human confirmation (`tests/test_overrides.py`)
  - `TEST 8`: Override without reason must fail (`tests/test_overrides.py`)
  - `TEST 9`: Operations Analyst cannot modify risk rules (403 Forbidden) (`tests/test_permissions.py`)
  - `TEST 10`: Release Manager can modify risk rules (200 OK) (`tests/test_permissions.py`)
  - `TEST 11`: Risk rule changes are audited (`tests/test_permissions.py`)
  - `TEST 12`: Invalid negative latency is rejected (`tests/test_data_validation.py`)
  - `TEST 13`: Error rate > 100% is rejected (`tests/test_data_validation.py`)
  - `TEST 14`: Duplicate release IDs are rejected (`tests/test_data_validation.py`)
  - `TEST 15`: Reproducible experiment metrics verification (`tests/test_experiment.py`)
- Automated test runners: `npm test` and `python3 tests/run_all_tests.py` passing 15/15 tests.

### 3.6 Reproducible Experiment Engine
- Implemented `scripts/run_experiment.py` and `scripts/run_experiment.ts`.
- Uses deterministic seed 42 to evaluate the benchmark cohort against deterministic rules R1–R6.
- Exports machine-readable artifacts: `experiments/results.json` and `experiments/results.csv`.
- Application UI dynamically reads and displays calculated results from `experiments/results.json`.

### 3.7 Resolution of the Baseline Discrepancy (38.2 min vs. ~48.5 min)
- Formally investigated the mathematical origin of both figures:
  - **38.2 minutes:** The true, unweighted arithmetic mean across all 60 scenarios in the evaluation cohort (including routine continues at 21.2 min, human reviews at 50.2 min, and rollbacks at 73.8 min).
  - **48.5 minutes:** The historic manual baseline for **elevated-risk and incident-grade scenarios** where incident bridges and cross-specialist coordination were convened.
- Selected **38.2 minutes** as the primary reproducible baseline for the main project claim.
- Fully documented in `docs/experiment_methodology.md` and explained in the UI.

### 3.8 Experimental Findings (Synthetic Benchmark)
- **Primary Baseline Decision Time:** 38.2 minutes (Median: 26.2 min, P25: 20.0 min, P75: 54.6 min)
- **Incident Subset Baseline:** 48.5 – 63.7 minutes
- **Adviser Target:** $\le 10.0$ minutes
- **Measured Adviser Decision Time:** **4.3 minutes** (Median: 4.0 min, P25: 2.8 min, P75: 5.5 min)
- **Decision Time Reduction:** **88.7%**
- **Decision Accuracy:** **93.3%** (56/60)
- **False Rollback Rate:** **3.3%** (2/60)
- **Missed Rollback Rate:** **0.0%** (0/60)
- **Human Review Rate:** **16.7%** (10/60)

### 3.9 Error Analysis Page
- Created UI page **Error Analysis** (`src/pages/ErrorAnalysisPage.tsx`).
- Full breakdown of classifications: Correct Rollback, Correct Continue, Correct Human Review, False Rollback, Missed Rollback.
- Detailed telemetry and root-cause explanation for each discrepancy; filterable and transparent.

### 3.10 Failure Mode Analysis
- Authored `docs/failure_mode_analysis.md` and added UI page **Failure Modes** (`src/pages/FailureModesPage.tsx`).
- 6 scenarios analyzed with Scenario, Inputs, Expected Behaviour, Actual Behaviour, Risks, Mitigations, and Test Case links.

### 3.11 Multi-Hospital Analytics & Release Comparison
- Enhanced **Dashboard** with multi-hospital comparative charts:
  - Risk by Hospital
  - Rollback Recommendations by Hospital
  - Latency and Error Rate Changes
  - Customer Impact Distribution
- Added dedicated **Compare Releases** page (`src/pages/CompareReleasesPage.tsx`) allowing side-by-side comparison of any two releases with numerical and visual delta badges.

### 3.12 Configurable Rule Audit & Strict RBAC
- Maintained configurable R1–R6 rules.
- Enforced strict authorization: Release Managers can edit; Operations Analysts are view-only.
- Added `/api/rules/audit` endpoint and UI viewer displaying immutable rule modification records.

### 3.13 Authentic Stakeholder Validation Module
- Overhauled `src/pages/StakeholderValidationPage.tsx` to collect un-fabricated feedback:
  - Role, Ease of use (1-5), Explanation clarity (1-5), Confidence (1-5), Decision usefulness (1-5), Evidence usefulness (1-5), Overall usability (1-5), and Comments.
  - Displays `"No stakeholder feedback collected yet."` when empty; displays real aggregated statistics only when actual responses are submitted.

---

## 4. Work Status Classification

### COMPLETED (Phase 2 Deliverables)
- [X] Project-specific README replacing all generic placeholders
- [X] Usability Walkthrough (interactive 13-step UI page)
- [X] Dedicated Ethics and Safety governance note (`docs/ethics_and_safety.md` + UI page)
- [X] Deployment Readiness checklist (`docs/deployment_checklist.md` + UI page)
- [X] Executable regression test suite with 15 tests covering all failure and permission cases
- [X] Reproducible experiment script (`scripts/run_experiment.py` / `scripts/run_experiment.ts`) with fixed seed 42
- [X] Automated generation of `experiments/results.json` and `experiments/results.csv`
- [X] Mathematical reconciliation of 38.2 min vs 48.5 min baseline discrepancy
- [X] Error Analysis UI page with confusion matrix and scenario inspection
- [X] Failure Modes UI page and detailed documentation (`docs/failure_mode_analysis.md`)
- [X] Release Comparison UI page (`src/pages/CompareReleasesPage.tsx`)
- [X] Multi-hospital analytics dashboard charts
- [X] Rule modification audit logging (`data/rules_audit.json` and UI viewer)
- [X] Strict RBAC enforcement (Release Manager vs Operations Analyst)
- [X] Data quality validation engine (rejecting negative latency, error > 100, duplicate IDs)
- [X] Real stakeholder feedback collection module (un-fabricated)
- [X] Technical architecture documentation (`docs/architecture.md`)
- [X] Technical approach comparison (`docs/technical_approach_comparison.md`)
- [X] Prominent advisory-only safeguards and no auto-rollback confirmation modal

### IN PROGRESS (Operational Refinements)
- Staging containerization (Docker compose profile for isolated staging evaluation).
- Additional simulated hospital tenant datasets (expanding from 5 to 20 hospital topologies).

### FUTURE (Phase 3 Roadmap)
- Enterprise SAML 2.0 / Okta Single Sign-On integration.
- Live OpenTelemetry and Prometheus push connectors.
- Cloud SQL / PostgreSQL enterprise persistence migration.
- Auxiliary unsupervised anomaly detection ML model for baseline drift forecasting.
- Formal hospital CMIO clinical governance committee trials.
